Scott Milsten sold $7.5M of ELF
other at e.l.f. Beauty, Inc.. 55,581 shares at an average of $134.56, traded Sep 10, 2025, filed Sep 12, 2025.
Score components
- +8RoleOther
- +25Trade size$7.5M at market
- +10Share of holdings soldSold 33% of holdings
- +15Cluster7 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -4.1%, 3m -43.5%, 6m -45.7%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001610717-25-000333, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Sep 10, 2025 | MOption exercise Common Stock, $0.01 par value10b5-1 | +17,281 | $17.00 | $294k | 134,687 | Sep 12, 2025 |
| Sep 10, 2025 | MOption exercise Common Stock, $0.01 par value10b5-1 | +33,300 | $26.84 | $894k | 167,987 | Sep 12, 2025 |
| Sep 10, 2025 | SOpen-market sale Common Stock, $0.01 par value10b5-1 | -5,476 | $132.54 | $726k | 162,511 | Sep 12, 2025 |
| Sep 10, 2025 | SOpen-market sale Common Stock, $0.01 par value10b5-1 | -8,927 | $133.48 | $1.2M | 153,584 | Sep 12, 2025 |
| Sep 10, 2025 | SOpen-market sale Common Stock, $0.01 par value10b5-1 | -30,218 | $134.58 | $4.1M | 123,366 | Sep 12, 2025 |
| Sep 10, 2025 | SOpen-market sale Common Stock, $0.01 par value10b5-1 | -6,753 | $135.36 | $914k | 116,613 | Sep 12, 2025 |
| Sep 10, 2025 | SOpen-market sale Common Stock, $0.01 par value10b5-1 | -1,101 | $136.52 | $150k | 115,112 | Sep 12, 2025 |
| Sep 10, 2025 | SOpen-market sale Common Stock, $0.01 par value10b5-1 | -1,006 | $137.96 | $139k | 114,506 | Sep 12, 2025 |
| Sep 10, 2025 | SOpen-market sale Common Stock, $0.01 par value10b5-1 | -2,100 | $139.00 | $292k | 112,406 | Sep 12, 2025 |
| Sep 10, 2025 | MOption exercise Stock Option (Right to Buy) (Common Stock)derivative10b5-1 | -17,281 | $0.00 | $0 | 0 | Sep 12, 2025 |
| Sep 10, 2025 | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -33,300 | $0.00 | $0 | 15,000 | Sep 12, 2025 |
Related signals
Other insiders at e.l.f. Beauty, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 25Weak | e.l.f. Beauty, Inc. | Tarang Amin Chief Executive Officer | $4.9M 47,000 shares | -26% | |
| 33Weak | e.l.f. Beauty, Inc. | Mandy J Fields See Remarks | $1.7M 16,065 shares | -15% | |
| 3Weak | e.l.f. Beauty, Inc. | Joshua Allen Franks SVP, Operations | $22k 200 shares | -0% | |
| 29Weak | e.l.f. Beauty, Inc. | Joshua Allen Franks SVP, Operations | $606k 5,512 shares | -4% | |
| 22Weak | e.l.f. Beauty, Inc. | Joshua Allen Franks SVP, Operations | $572k 5,718 shares | -4% | |
| 40Moderate | e.l.f. Beauty, Inc. | Lauren Cooks Levitan director | $96k 1,034 shares | -9% | |
| 28Weak | e.l.f. Beauty, Inc. | Kory Marchisotto See Remarks | $1.1M 12,173 shares | -7% | |
| 33Weak | e.l.f. Beauty, Inc. | Tarang Amin Chief Executive Officer | $3.9M 50,164 shares | -31% | |
| 38Weak | e.l.f. Beauty, Inc. | Jennifer Catherine Hartnett Chief Commercial Officer | $2.0M 25,357 shares | -47% | |
| 68Notable | e.l.f. Beauty, Inc. | Tarang Amin Chief Executive Officer | $822k 15,829 shares | -10% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.